You are here

Front > Search FHI 360

Search FHI 360

Start a New Search

Search within these results

ZambiaKenya

24 Results Found

  • Publication

    MOSAIC Across the Product Introduction Framework

    This brief describes MOSAIC’s activities as they relate to the five stages of the pre-exposure prophylaxis (PrEP) product introduction framework.
  • Tools

    Envision FP: Seven Years of Success

    This flipbook describes Envision FP’s achievements in pharmaceutical development, clinical research and product introduction from 2015 to 2022.
  • News

    Hormonal IUD added to product catalogs, access expands globally

    FHI 360 joins global partners in celebrating the addition of the levonorgestrel-releasing intrauterine device (IUD), also known as the hormonal IUD, to the USAID and UNFPA product catalogs.
  • News

    FHI 360 commends updated guidance on contraception for women at high risk of HIV

    FHI 360 welcomes the World Health Organization’s updated guidance on contraceptive use by women at high risk of acquiring HIV infection and applauds the thoughtful, thorough review process that led to these new recommendations.
  • Published research

    HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: A randomised, multicentre, open-label trial

    The ECHO trial, a randomized clinical trial, was developed to address a long-standing question about the possible association of hormonal contraceptives with increased HIV acquisition risk. This article presents the data from research sites in Eswatini, Kenya, South Africa and Zambia. The results indicate there were no substantial differences in HIV incidence associated with use of three licensed contraceptive methods and supports continued and expanded access to these methods.
  • News

    FHI 360 responds to release of landmark ECHO Study results

    FHI 360 responds to the release of the landmark ECHO Study results.
  • Past Project

    Learning about Expanded Access and Potential of the LNG-IUS (LEAP LNG-IUS) Initiative

    The LEAP LNG-IUS Initiative will generate evidence to determine if and how the levonorgestrel intrauterine system might increase contraceptive use and continuation rates in sub-Saharan Africa.
  • Feature

    Water, sanitation and hygiene programs lead to healthier households and communities

    This summer, FHI 360 marked the close of the WASHplus project, which has been the U.S. Agency for International Development’s global flagship activity for environmental health since 2010.
  • Published research

    Men's understanding of and experiences during the postcircumcision abstinence period: Results from a field study of ShangRing circumcision during routine clinical services in Kenya and Zambia

    Men’s understanding of counseling messages after voluntary medical male circumcision (VMMC) plays a role in whether they follow them. In this study, most men reported awareness of and adherence to recommendations for post-VMMC abstinence, and a minority of men reported early resumption of intercourse with infrequent condom use. Results may be useful to improve counseling messages as scale-up of VMMC for HIV prevention continues in sub-Saharan Africa.
  • News

    ECHO Study of hormonal contraception and HIV begins

    FHI 360 and partners embark on a landmark study designed to fill a critical gap in the scientific evidence on the relationship between HIV acquisition and hormonal contraceptives.